On Thursday, May 27, 2010, The House Committee on Oversight and Government Reform will hold a hearing to examine the recall of popular pediatric medicines recalled by Johnson & Johnson subsidiary McNeil Pharmaceuticals. The hearing entitled "Johnson & Johnson's Recall of Children's Tylenol and Other Medicines" will take place at 10:00 a.m. in room 2154 Rayburn House Office Building.

The witnesses scheduled to testify include:

Panel I

Dr. Joshua Sharfstein
Principal Deputy Commissioner
Food and Drug Administration

Ms. Deborah M. Autor
Director of the Office of Compliance
Center for Drug Evaluation  and Research
Food and Drug Administration

Mr. Michael A. Chappell
Acting Associate Commissioner for Regulatory Affairs
Food and Drug Administration

Panel II

Ms. Colleen Goggins
Worldwide Chairman, Consumer Group
Johnson & Johnson